Fortis Healthcare Ltd fundamental analysis highlights key financial metrics including Market Cap (₹39,499.41 crore), PE Ratio (70), Debt to Equity (13.50) and Return on Equity (7.19%), reflecting the company’s financial health and market valuation.
Fortis Healthcare Ltd Overview
Fortis Healthcare Ltd is an integrated healthcare delivery service provider operating in the healthcare sector, offering a wide range of medical services and specialities.
The company’s current market cap is ₹39,499.41 crore. It is listed on the stock exchange, though the specific exchange and listing date are not mentioned. The stock is 3.69% away from its 52-week high and 66.73% above its 52-week low.
Fortis Healthcare Financial Results
Fortis Healthcare Ltd reported sales of ₹6,893 crores in FY 24, with expenses of ₹5,625 crores, leading to an operating profit of ₹1,268 crores. The company’s net profit stood at ₹645 crores, while the EPS reached ₹7.93. The balance sheet reflected total liabilities of ₹13,289 crores.
1. Revenue Trend: Fortis Healthcare’s revenue increased to ₹6,893 crores in FY 24, compared to ₹6,298 crores in FY 23, showing consistent growth.
2. Equity and Liabilities: Equity capital remained constant at ₹755 crores in FY 24, while reserves increased to ₹6,906 crores. Non-current liabilities dropped to ₹1,562 crores in FY 24 from ₹2,907 crores in FY 23.
3. Profitability: The operating profit margin improved to 18.29% in FY 24 from 17.32% in FY 23, indicating higher efficiency in managing costs.
4. Earnings per Share (EPS): EPS slightly increased to ₹7.93 in FY 24 from ₹7.80 in FY 23, reflecting improved profitability per share.
5. Return on Net Worth (RoNW): With consistent reserves growth, Fortis Healthcare maintained a positive return on net worth, showing its capacity to generate returns for shareholders.
6. Financial Position: Total assets increased to ₹13,289 crores in FY 24 from ₹12,434 crores in FY 23, reflecting overall growth in the company’s financial position.
Fortis Healthcare Financial Analysis
| FY 24 | FY 23 | FY 22 | |
| Sales | 6,893 | 6,298 | 5,718 |
| Expenses | 5,625 | 5,196 | 4,649 |
| Operating Profit | 1,268 | 1,101 | 1,069 |
| OPM % | 18.29 | 17.32 | 18.61 |
| Other Income | 54 | 135 | 342 |
| EBITDA | 1,306 | 1,163 | 1,096 |
| Interest | 131 | 129 | 147 |
| Depreciation | 343 | 316 | 301 |
| Profit Before Tax | 848 | 792 | 964 |
| Tax % | 25 | 23 | 21 |
| Net Profit | 645 | 633 | 790 |
| EPS | 7.93 | 7.8 | 7.35 |
| Dividend Payout % | 12.61 | 12.82 | 0 |
* Consolidated Figures in Rs. Crores
Fortis Healthcare Ltd Company Metrics
Fortis Healthcare Ltd’s company metrics include a market capitalization of ₹39,499.41 crore, a book value per share of ₹102 and a face value of ₹10. With a debt-to-equity ratio of 13.50, a return on equity of 7.19% and a 0.19% dividend yield, these figures underscore the company’s financial position and investment profile.
Market Capitalization: Market Capitalization represents the total market value of Fortis Healthcare’s outstanding shares, amounting to ₹39,499.41 crore.
Book Value: The book value per share of Fortis Healthcare is ₹102, indicating the value of the company’s net assets divided by its outstanding shares.
Face Value: The face value of Fortis Healthcare’s shares is ₹10, which is the original cost of the shares as stated on the certificate.
Asset Turnover Ratio: The asset turnover ratio of 0.58 measures how efficiently Fortis Healthcare uses its assets to generate revenue.
Total Debt: The total debt is ₹1,155.01 crore, indicating Fortis Healthcare’s debt obligations.
Return on Equity (ROE): The ROE of 7.19% measures Fortis Healthcare’s profitability in generating income from its equity investments.
EBITDA (Q): The quarterly EBITDA of ₹356.32 crore represents Fortis Healthcare’s earnings before interest, taxes, depreciation and amortization.
Dividend Yield: The dividend yield of 0.19% shows the annual dividend payment as a percentage of Fortis Healthcare’s current share price, indicating the return on investment from dividends alone.
Fortis Healthcare Ltd Stock Performance
Fortis Healthcare Ltd delivered a return on investment (ROI) of 79.1% over one year, 29.9% over three years and 34.1% over five years, reflecting steady growth for investors over different time horizons.
| Period | Return on Investment (%) |
| 1 Year | 79.1 |
| 3 Years | 29.9 |
| 5 Years | 34.1 |
Example: If you had invested ₹1,000 in Fortis Healthcare Ltd:
1 year ago, your investment would now be worth ₹1,791.
3 years ago, your investment would have grown to ₹1,299.
5 years ago, your investment would have increased to ₹1,341.
Fortis Healthcare Limited Peer Comparison
Fortis Healthcare Ltd shows a P/E ratio of 69.96 and an ROE of 7.85%, delivering a one-year return of 79.09%. It lags behind Max Healthcare’s 85.27% return but outperforms Apollo Hospitals’ 39.73%. Global Health exhibits higher ROE and better overall growth at 17.93%.
| Name | CMP Rs. | Mar Cap Rs.Cr. | P/E | ROE % | EPS 12M Rs. | 1Yr return % | ROCE % | Div Yld % |
| Apollo Hospitals | 7122 | 102403.43 | 98.84 | 13.67 | 72.14 | 39.73 | 15.55 | 0.22 |
| Max Healthcare | 1030.4 | 100168.49 | 95.05 | 13.37 | 10.84 | 85.27 | 16 | 0.15 |
| Fortis Health. | 594.95 | 44916.24 | 69.96 | 7.85 | 8.65 | 79.09 | 10.34 | 0.17 |
| Global Health | 1092.95 | 29350.89 | 60.85 | 17.93 | 17.97 | 56.86 | 19.32 | 0 |
| Dr Lal Pathlabs | 3349.95 | 27996.96 | 73.39 | 20.36 | 45.7 | 40.4 | 25.17 | 0.72 |
| Narayana Hrudaya | 1225.6 | 25046.46 | 31.05 | 31.43 | 39.47 | 15.4 | 26.54 | 0.33 |
| Poly Medicure | 2376.2 | 24068.66 | 89.27 | 19.08 | 28.1 | 72.36 | 23.62 | 0.13 |
Fortis Healthcare Shareholding Pattern
Fortis Healthcare Ltd holds a promoter stake of 31.17% as of June 2024, unchanged from previous quarters. Foreign Institutional Investors (FIIs) maintain 23.31%, with slight fluctuations. Domestic Institutional Investors (DIIs) have increased to 32.31%, while retail and others have reduced their holding to 13.22%.
| All values in % | Jun-24 | Mar-24 | Dec-23 |
| Promoters | 31.17 | 31.17 | 31.17 |
| FII | 23.31 | 23.24 | 23.72 |
| DII | 32.31 | 31.14 | 29.42 |
| Retail & others | 13.22 | 14.44 | 15.71 |
Fortis Healthcare Limited History
Fortis Healthcare Limited is an India-based integrated healthcare delivery service provider. The company operates a network of multi-speciality hospitals and diagnostics centres, offering a wide range of medical services across various specialities including cardiac sciences, oncology and neurosurgery.
The company’s healthcare verticals primarily consist of hospitals, diagnostics and daycare speciality facilities. Fortis Healthcare manages approximately 27 healthcare facilities with 4500 operational beds and over 400 diagnostics centres, serving patients in India, the United Arab Emirates and Sri Lanka.
Fortis Healthcare’s subsidiaries include Escorts Heart Institute and Research Centre Limited, Fortis Health Staff Limited and Fortis Asia Healthcare Pte. Ltd, among others. The company’s extensive network and diverse medical offerings position it as a significant player in the healthcare sector.
How To Invest In Fortis Healthcare Ltd Share?
To invest in Fortis Healthcare Ltd shares, open a demat account with Alice Blue. Research the company’s financials and market performance thoroughly to make an informed decision.
Use the trading platform to place a buy order for your desired number of shares. Regularly monitor your investment and stay informed about market trends and relevant news.
Consider diversifying your portfolio to manage risk effectively. If needed, seek professional advice for personalized investment strategies tailored to your financial goals and risk tolerance.
Fortis Healthcare Limited Fundamental Analysis – FAQs
Fundamental Analysis of Fortis Healthcare Ltd reveals a Market Cap of ₹39,499.41 crore, PE Ratio of 70, Debt-equity ratio of 13.50 and Return on Equity of 7.19%. These metrics provide insight into the company’s financial health and market valuation.
The Market Cap of Fortis Healthcare Ltd is ₹39,499.41 crore. This figure represents the total market value of the company’s outstanding shares, indicating its size and perceived value in the stock market.
Fortis Healthcare Limited is an integrated healthcare delivery service provider based in India. It operates a network of multi-speciality hospitals and diagnostics centres, offering a wide range of medical services across various specialities in India, UAE and Sri Lanka.
The ownership information for Fortis Healthcare Ltd is not provided in the given data. Typically, such companies are owned by a combination of institutional investors, retail investors and potentially strategic partners in the healthcare sector.
The main shareholders of Fortis Healthcare Ltd are not specified in the provided information. Generally, for public healthcare companies, major shareholders can include institutional investors, mutual funds, company founders and individual investors holding significant portions of the company’s stock.
Fortis Healthcare operates in the healthcare industry. Specifically, it is part of the integrated healthcare delivery services sector, providing a range of medical services including hospital care, diagnostics and speciality daycare facilities.
To invest in Fortis Healthcare Ltd shares, open a demat account with Alice Blue. Research the company thoroughly, then use the platform to place a buy order. Monitor your investment regularly and stay informed about market trends. Consider diversifying your portfolio and seek professional advice if needed.
Determining if Fortis Healthcare is overvalued or undervalued requires a comprehensive analysis of its financials, market position and future prospects. The PE ratio of 70 suggests potential overvaluation, but other factors should be considered for a conclusive assessment.
We hope you’re clear on the topic, but there’s more to explore in stocks, commodities, mutual funds, and related areas. Here are important topics to learn about.
Disclaimer: The above article is written for educational purposes and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
